Search

Your search keyword '"Gragnano, Felice"' showing total 16 results
Start Over Author "Gragnano, Felice" Journal international journal of cardiology
16 results on '"Gragnano, Felice"'

1. ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor

Author

Benenati, Stefano, Gragnano, Felice, Scalamera, Riccardo, De Sio, Vincenzo, Capolongo, Antonio, Cesaro, Arturo, Annibali, Gianmarco, Campagnuolo, Salvatore, Silverio, Angelo, Bellino, Michele, Centore, Mario, Schettino, Matteo, Bertero, Edoardo, Caretta, Giorgio, Rezzaghi, Marco, Veneziano, Francesco, De Nardo, Davide, De Rosa, Gennaro, De Luca, Leonardo, Galasso, Gennaro, Menozzi, Alberto, Musumeci, Giuseppe, Cirillo, Plinio, Calabrò, Paolo, and Porto, Italo

Published
2024
Full Text
View/download PDF

2. Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology

Author

Andò, Giuseppe, Pelliccia, Francesco, Saia, Francesco, Tarantini, Giuseppe, Fraccaro, Chiara, D'Ascenzo, Fabrizio, Zimarino, Marco, Di Marino, Mario, Niccoli, Giampaolo, Porto, Italo, Calabrò, Paolo, Gragnano, Felice, De Rosa, Salvatore, Piccolo, Raffaele, Moscarella, Elisabetta, Fabris, Enrico, Montone, Rocco Antonio, Spaccarotella, Carmen, Indolfi, Ciro, Sinagra, Gianfranco, and Perrone Filardi, Pasquale

Published
2024
Full Text
View/download PDF

8. Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry

Author

Cesaro, Arturo, primary, Gragnano, Felice, additional, Calabrò, Paolo, additional, Moscarella, Elisabetta, additional, Santelli, Francesco, additional, Fimiani, Fabio, additional, Patti, Giuseppe, additional, Cavallari, Ilaria, additional, Antonucci, Emilia, additional, Cirillo, Plinio, additional, Pignatelli, Pasquale, additional, Palareti, Gualtiero, additional, Pelliccia, Francesco, additional, Bossone, Eduardo, additional, Pengo, Vittorio, additional, Gresele, Paolo, additional, Marcucci, Rossella, additional, Schiavo, Alessandra, additional, Vergara, Andrea, additional, Pastori, Daniele, additional, Menichelli, Danilo, additional, Grossi, Guido, additional, Di Serafino, Luigi, additional, Taglialatela, Vittorio, additional, del Pinto, Maurizio, additional, and Gugliemini, Giuseppe, additional

Published
2021
Full Text
View/download PDF

9. Natural history of left ventricular hypertrophy in infants of diabetic mothers

Author

Monda, Emanuele, primary, Verrillo, Federica, additional, Altobelli, Ippolita, additional, Lioncino, Michele, additional, Caiazza, Martina, additional, Rubino, Marta, additional, Cirillo, Annapaola, additional, Fusco, Adelaide, additional, Esposito, Augusto, additional, Di Fraia, Francesco, additional, Pacileo, Roberta, additional, Gragnano, Felice, additional, Passariello, Annalisa, additional, Calabrò, Paolo, additional, Russo, Maria Giovanna, additional, and Limongelli, Giuseppe, additional

Published
2021
Full Text
View/download PDF

11. Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team

Author

Pelliccia, Francesco, primary, Alfieri, Ottavio, additional, Calabrò, Paolo, additional, Cecchi, Franco, additional, Ferrazzi, Paolo, additional, Gragnano, Felice, additional, Kaski, Juan Pablo, additional, Limongelli, Giuseppe, additional, Maron, Martin, additional, Rapezzi, Claudio, additional, Seggewiss, Hubert, additional, Yacoub, Magdi H., additional, and Olivotto, Iacopo, additional

Published
2020
Full Text
View/download PDF

12. Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy

Author

Limongelli, Giuseppe, primary, Monda, Emanuele, additional, Tramonte, Stefania, additional, Gragnano, Felice, additional, Masarone, Daniele, additional, Frisso, Giulia, additional, Esposito, Augusto, additional, Gravino, Rita, additional, Ammendola, Ernesto, additional, Salerno, Gemma, additional, Rubino, Marta, additional, Caiazza, Martina, additional, Russo, Mariagiovanna, additional, Calabrò, Paolo, additional, Elliott, Perry Mark, additional, and Pacileo, Giuseppe, additional

Published
2020
Full Text
View/download PDF

14. Are we ready for a gender-specific approach in interventional cardiology?

Author

Calabrò, Paolo, primary, Niccoli, Giampaolo, additional, Gragnano, Felice, additional, Grove, Erik Lerkevang, additional, Vergallo, Rocco, additional, Mikhailidis, Dimitri P., additional, Patti, Giuseppe, additional, Spaccarotella, Carmen, additional, Katsiki, Niki, additional, Masiero, Giulia, additional, Ueshima, Daisuke, additional, Pinar, Eduardo, additional, Chieffo, Alaide, additional, Ussia, Gian Paolo, additional, Eitel, Ingo, additional, and Tarantini, Giuseppe, additional

Published
2019
Full Text
View/download PDF

15. Natural history of left ventricular hypertrophy in infants of diabetic mothers.

Author

Monda, Emanuele, Verrillo, Federica, Altobelli, Ippolita, Lioncino, Michele, Caiazza, Martina, Rubino, Marta, Cirillo, Annapaola, Fusco, Adelaide, Esposito, Augusto, Di Fraia, Francesco, Pacileo, Roberta, Gragnano, Felice, Passariello, Annalisa, Calabrò, Paolo, Russo, Maria Giovanna, and Limongelli, Giuseppe

Subjects
*MOTHER-infant relationship, *LEFT ventricular hypertrophy, *NATURAL history, *NOONAN syndrome, *BIOMARKERS
Abstract

This study sought to describe the characteristics and the natural course of left ventricular hypertrophy (LVH) in a well-characterized consecutive cohort of infants of diabetic mothers (IDMs). Sixty consecutive IDMs with LVH have been retrospectively identified and enrolled in the study. All IDMs were evaluated at baseline and every 6 months until LV wall thickness regression, defined as the decrease of wall thickness measurement into the normal reference range for cardiac parameters (z-score > −2 and < 2). A comprehensive assessment was performed in those patients with diagnostic markers suggestive of a different cause and/or without significant reduction of the LVH during follow-up. At 1-year follow-up, all IDMs showed a significant reduction of maximal wall thickness MWT (6.00 mm [IQR 5.00–712] vs. 5.50 mm [IQR 5.00–6.00], p-value <0.001; MWT-z-score: 4.86 [IQR 3.93–7.61] vs. 1.72 [IQR 1.08–2.85], p-value <0.001) compared to baseline, and all patients showed LV wall thickness regression or residual mild or moderate LVH (57%, 28%, and 12%, respectively), except 2 patients with persistent severe LVH, that after a comprehensive clinical-genetic assessment were diagnosed as Noonan syndrome with multiple lentigines. At multivariate analysis, MWT was negatively associated with LV wall thickness regression at 1-year follow-up (MWT-mm: OR 0.48[0.29–0.79], p-value = 0.004; MWT-z-score: OR 0.71[0.56–0.90], p-value = 0.004). LVH in IDMs represents a benign condition with complete regression during the first years of life. In those patients without LV wall thickness regression, combined with clinical markers suggesting a specific disease, a complete work-up is required for a definite diagnosis. [Display omitted] • 57% of IDMs showed left ventricular wall thickness regression in the first year of age. • Two IDMs with persistent severe LVH at 1-year follow-up were diagnosed as NSML. • All IDMs showed a LV wall thickness regression in the first 6 years of life. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

16. Multimodality evaluation of cardiac injury in COVID-19: Getting to the heart of the matter

Author

Arturo Cesaro, Francesco Pelliccia, Felice Gragnano, Paolo Calabrò, Gragnano, Felice, Cesaro, Arturo, Pelliccia, Francesco, and Calabro', Paolo

Subjects
CMR, Cardiac Magnetic Resonance, COVID-19, COronaVIrus Disease 19, CAD, coronary artery disease, Multimodal Imaging, HF, heart failure, CVD, Cardiovascular Diseases, RT-PCR, reverse-transcriptase-polymerase-chain reaction, Pandemic, Medicine, Prospective Studies, cardiovascular imaging, Follow-up, Heart, FoCUS, Focus Cardiac UltraSound, Cardiovascular disease, STEMI, ST-Elevation Myocardial Infarction, Hospitals, ABG, arterial-blood gas, HTN, arterial hypertension, RV, right ventricle, Myocarditis, Editorial, Echocardiography, MI, myocardial infarction, hs-Trop, high sensitive troponin, Cardiology and Cardiovascular Medicine, A&E, Accident & Emergency Department, 2019-20 coronavirus outbreak, Heart Injury, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), NIV, Non-invasive ventilation, Article, Multimodality, COVID-19, cardiovascular disease, multimodality, pandemic, SARS-CoV-2, 6MWT, 6 min walking test, Humans, cardiovascular diseases, Multimodal imaging, PCI, percutaneous coronary intervention, business.industry, COVID-ICU, COVID intensive care unit, SARS-CoV-2, Severe Acute Respiratory Syndrome CoronaVirus 2, IMV, invasive mechanical ventilation, LV, left ventricle, Heart Injuries, COPD, chronic obstructive pulmonary disease, LAD, left anterior descending artery, Emergency medicine, CPAP, continuous positive airway pressure, CT, chest computed tomography, Cardiovascular magnetic resonance, ECG, electrocardiogram, business, Follow-Up Studies
Abstract

Background Cardiovascular disease (CVD) can occur in COVID-19 and has impact on clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in survivors is limited. Aim of this prospective study carried out on consecutive unselected COVID-19 population, was to assess: 1) CVD occurrence among hospitalized COVID-19 patients, 2) persistence or new onset of CVD at one-month and one-year follow-up. Methods Over 30 days n = 152 COVID-19 patients underwent cardiovascular evaluation. Standard electrocardiogram (ECG), Troponin and echocardiography were integrated by further tests when indicated. Medical history, arterial blood gas, blood tests, chest computed tomography and treatment were recorded. CVD was defined as the occurrence of a new condition during the hospitalization for COVID-19. Survivors attended a one-month follow-up visit and a one-year telephone follow-up. Results Forty-two patients (28%) experienced a wide spectrum of CVD with acute myocarditis being the most frequent. Death occurred in 32 patients (21%) and more frequently in patients who developed CVD (p = 0.032). After adjustment for confounders, CVD was independently associated with death occurrence. At one-month follow-up visit, 7 patients (9%) presented persistent or delayed CVD. At one-year telephone follow-up, 57 patients (48%) reported persistent symptoms. Conclusion Cardiovascular evaluation in COVID-19 patients is crucial since the occurrence of CVD in hospitalized COVID-19 patients is common (28%), requires specific treatment and increases the risk of in-hospital mortality. Persistence or delayed presentation of CVD at 1-month (9%) and persistent symptoms at 1-year follow-up (48%) suggest the need for monitoring COVID-19 survivors., Graphical abstract Unlabelled Image

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results